Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ta-Chou Vincent Ng
Observed names:
Ta-Chou (Vincent) Ng,
Ta-Chou Ng
Institution:
Foundation Medicine (United States)
Observed institutions:
National Taiwan University,
Massachusetts General Hospital,
Institute of Statistical Science, Academia Sinica,
Foundation Medicine (United States),
Academia Sinica,
University of Sheffield,
National Cheng Kung University
show all 7
ORCID:
0000-0003-1446-5864
Observed ORCID:
0000-0003-1446-5864
OpenAlex ID:
A5080015292
Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset
2020
·
Hao-Yuan Cheng
, Shu-Wan Jian
, et al.
·
JAMA Internal Medicine
·
927
PDF
The Timing of COVID-19 Transmission
2020
·
Luca Ferretti
, Alice Ledda
, et al.
·
SSRN Electronic Journal
·
129
Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan
2021
·
Ta-Chou Ng
, Hao-Yuan Cheng
, et al.
·
JAMA Internal Medicine
·
70
PDF
High transmissibility of COVID-19 near symptom onset
2020
·
Hao-Yuan Cheng
, Shu-Wan Jian
, et al.
·
medRxiv
·
70
PDF
Is Hyperuricemia, an Early-Onset Metabolic Disorder, Causally Associated with Cardiovascular Disease Events in Han Chinese?
2019
·
Kuang-Mao Chiang
, Yuh-Chyuan Tsay
, et al.
·
Journal of Clinical Medicine
·
54
PDF
Spatially Adjusted Time-varying Reproductive Numbers: Understanding the Geographical Expansion of Urban Dengue Outbreaks
2019
·
Ta-Chou Ng
, Tzai-Hung Wen
·
Scientific Reports
·
38
PDF
Epidemiological Benchmarks of the COVID-19 Outbreak Control in China after Wuhan’s Lockdown: A Modelling Study with An Empirical Approach
2020
·
Chu Chang Ku
, Ta-Chou Ng
, et al.
·
SSRN Electronic Journal
·
28
Improving the Use of Mortality Data in Public Health: A Comparison of Garbage Code Redistribution Models
2019
·
Ta-Chou Ng
, Wei-Cheng Lo
, et al.
·
American Journal of Public Health
·
15
Epidemiological Benchmarks of the COVID-19 Outbreak Control in China After Wuhan's Lockdown: A Modelling Study with an Empirical Approach
2020
·
Chu Chang Ku
, Ta-Chou Ng
, et al.
·
SSRN Electronic Journal
·
9
Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
·
Cancer Research Communications
·
3
PDF
Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection
2025
·
Tanayott Thaweethai
, Caitlin A. Selvaggi
, et al.
·
BMC Infectious Diseases
·
1
COVID-19 Transmission Conclusions Justified by the Analysis Results?—Reply
2020
·
Hao-Yuan Cheng
, Ta-Chou Ng
, et al.
·
JAMA Internal Medicine
·
1
Clinical validity of FoundationOne CDx assay to identify HRR -positive or BRCA -positive mCSPC patients in the phase 3 AMPLITUDE study.
2026
·
Usha Singh
, Victoria Zadorozhny
, et al.
·
Journal of Clinical Oncology
Figure 1 from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table S6. from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table 2 from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Supplementary Methods from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table 1 from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table 3 from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table S1. from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table S2. from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table 4 from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Data from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table S5. from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Table S3. from Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer
2025
·
Rona Yaeger
, Jean-François Martini
, et al.
Show more works
View as search
Works count:
26
Citation count:
1,345
H-index:
9
I10-index:
8
Year
Topic
Type